|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 肝纤维化中西医结合诊疗指南显示文摘肝纤维化在国际疾病分类(ICD-10)中可作为一种病名(K74-001),但主要是一种组织病理学概念。肝纤维化指肝组织内细胞外基质(ECM)成分过度增生与异常沉积,导致肝脏结构或(和)功能异常的病理变化,结构上表现为肝窦毛细血管化与肝小叶内以及汇管区纤维化;功能上可以表现为肝功能减退、门静脉高压等。其形成机制主要由于肝炎病毒、乙醇、药物与毒物、血吸虫、代谢和遗传、胆汁淤积、自身免疫性肝病等多种损伤因素长期慢性刺激肝脏,使肝窦内肝星状细胞的活化,胶原等ECM成分代谢失衡,生成大于降解,促使肝脏ECM沉积与组织结构重构。 | Liver Disease Committee,Chinese Association of Integrative Medicine. | 2006 | 中华肝脏病杂志2006，14，11： | 269 |
| 2 | 家庭血压监测中国专家共识显示文摘自动的电子血压计正在进入家庭。家庭血压监测已成为血压管理的重要组成部分。近年来,美国、欧洲与日本相继制定了家庭血压监测指南。我国家庭血压监测的研究工作正处起步阶段,尚不能完全根据我国相关研究的结果制定指南。随着高血压患者家庭血压管理意识的迅速提高,许多家庭拥有了自动的电子血压计,同时也在进行家庭血压测量。为了促进家庭血压监测的健康发展,需要对家庭血压监测进行适当的规范。因此,参考国外有关指南并经广泛、深入的讨论,制定本共识文件。就血压计的选择与校准、血压测量的频率(次数)与时间(天数)以及家庭血压的正常值等重要问题提出了建议。 | Chinese Hypertension Committee of the Chinese Medical Doctors Association, Chinese Hypertension League, Chinese Society of Cardiology of the Chinese Medical Association | 2012 | 中华高血压杂志2012，20，6： | 83 |
| 3 | 糖尿病足诊治指南显示文摘糖尿病足是糖尿病严重而又治疗费用高的慢性并发症。该文系统介绍糖尿病足的基本概念,糖尿病下肢缺血与下肢动脉硬化合并糖尿病的区别,糖尿病病变的特点与预后。着重介绍糖尿病足的治疗,包括下肢动脉介入治疗、动脉旁路重建、干细胞,移植。对大动脉、中等动脉和小动脉治疗方案的选择,以及围手术期处理等都进行了详细的论述。 | China Branch of the International Union of Angiology Diabetic Foot Committee | 2013 | 介入放射学杂志2013，22，9： | 269 |
| 4 | 2015年全国细菌耐药监测报告显示文摘为贯彻落实《抗菌药物临床应用指导原则》,加强医疗机构抗菌药物临床应用的监督和管理,国家卫生计生委合理用药专家委员会和全国细菌耐药监测网日前发布了《2015年全国细菌耐药监测报告》,现予全文刊登,以促进合理用药,提高抗菌药物临床应用水平。 | Committee of Experts on Rational Drug Use, National Health and Family Planning Commission of the P.R.China | 2016 | 中国执业药师2016，0，3： | 206 |
| 5 | 2018 Chinese Guidelines for Prevention and Treatment of Hypertension——A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension显示文摘Table of Contents Preamble 1 Prevalence of hypertension in Chinese population 1.1 Prevalence,incidence and epidemic trend of hypertension in Chinese population 1.2 Awareness,treatment and control of Hypertension in China 1.3 Important risk factors for hypertension in Chinese population 2 Hypertension and cardiovascular risk 2.1 Relationship between blood pressure and cardiovascular risk 2.2 Cardiovascular risk characteristics of hypertension population in China 3 Diagnostic evaluation 3.1 Medical history 3.2 Physical examination 3.3 Laboratory examinations 3.4 Genetic analysis 3.5 BP measurement 3.6 Evaluation of target organ damage. | Joint Committee for Guideline Revision Chinese Hypertension League Chinese Society of Cardiology Hypertension Committee of the Chinese Medical Doctor Association Hypertension Branch of the China Association for the Promotion of International Exchanges of Health Care Hypertension Branch of the Chinese Geriatrics Society Li–Sheng LIU | 2019 | Journal of Geriatric Cardiology2019，16，3： | 95 |
| 6 | China Stroke Statistics 2019:A Report From the National Center for Healthcare Quality Management in Neurological Diseases,China National Clinical Research Center for Neurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations显示文摘China faces the greatest challenge from stroke in the world.The death rate for cerebrovascular diseases in China was 149.49 per 100000,accounting for 1.57 million deaths in 2018.It ranked third among the leading causes of death behind malignant tumours and heart disease.The age-standardised prevalence and incidence of stroke in 2013 were 1114.8 per 100000 population and 246.8 per 100000 person-years,respectively.According to the Global Burden of Disease Study 2017,the years of life lost(YLLs)per 100000 population for stroke increased by 14.6%;YLLs due to stroke rose from third highest among all causes in 1990 to the highest in 2017.The absolute numbers and rates per 100000 population for all-age disability-adjusted life years(DALYs)for stroke increased substantially between 1990 and 2017,and stroke was the leading cause of all-age DALYs in 2017.The main contributors to cerebrovascular diseases include behavioural risk factors(smoking and alcohol use)and pre-existing conditions(hypertension,diabetes mellitus,dyslipidaemia and atrial fibrillation(AF)).The most prevalent risk factors among stroke survivors were hypertension(63.0%-84.2%)and smoking(31.7%-47.6%).The least prevalent was AF(2.7%-7.4%).The prevalences for major risk factors for stroke are high and most have increased over time.Based on the latest national epidemiological data,26.6%of adults aged≥15 years(307.6 million adults)smoked tobacco products.For those aged≥18 years,age-adjusted prevalence of hypertension was 25.2%;adjusted prevalence of hypercholesterolaemia was 5.8%;and the standardised prevalence of diabetes was 10.9%.For those aged≥40 years,the standardised prevalence of AF was 2.31%.Data from the Hospital Quality Monitoring System showed that 3010204 inpatients with stroke were admitted to 1853 tertiary care hospitals during 2018.Of those,2466785(81.9%)were ischaemic strokes(ISs);447609(14.9%)were intracerebral haemorrhages(ICHs);and 95810(3.2%)were subarachnoid haemorrhages(SAHs).The average age of patients admitted was 66 years old,and nearly 60%were male.A total of 1555(0.1%),2774(0.6%)and 1347(1.4%)paediatric strokes(age<18 years)were identified among IS,ICH and SAH,respectively.Over one-third(1063892(35.3%))of the patients were covered by urban resident basic medical insurance,followed by urban employee basic medical insurance(699513(23.2%))and new rural cooperative medical schema(489361(16.3%)).The leading risk factor was hypertension(67.4%for IS,77.2%for ICH and 49.1%for SAH),and the leading comorbidity was pneumonia or pulmonary infection(10.1%for IS,31.4%for ICH and 25.2%for SAH).In-hospital death/discharge against medical advice rate was 8.3%for stroke inpatients,ranging from 5.8%for IS to 19.5%for ICH.The median and IQR of length of stay was 10.0(7.0-14.0)days,ranging from 10.0(7.0-13.0)in IS to 14.0(8.0-22.0)in SAH.Data from the Chinese Stroke Center Alliance demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS,ICH and SAH were 0.77±0.21,0.72±0.28 and 0.59±0.32,respectively. | Yong-Jun Wang Zi-Xiao Li Hong-Qiu Gu Yi Zhai Yong Jiang Xing-Quan Zhao Yi-Long Wang Xin Yang Chun-Juan Wang Xia Meng Hao Li Li-Ping Liu Jing Jing Jing Wu An-Ding Xu Qiang Dong David Wang Ji-Zong Zhao On behalf of China Stroke Statistics 2019 Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，3： | 181 |
| 7 | 胆汁淤积性肝病诊断治疗专家共识:2015年更新显示文摘胆汁淤积性肝病是一组以胆汁淤积为主要表现的临床常见疾病。近年来,对该病的诊断治疗取得迅速进展。2009年及2013年《中华实验和临床感染病杂志(电子版)》与《中国肝脏病杂志(电子版)》编辑部组织国内部分专家分别对相关资料进行整理分析,形成了《胆汁淤积性肝病诊断治疗专家共识》的2009版及2013版。近2年来,胆汁淤积性肝病诊断治疗的资料进一步积累。 | Expert Committee on the 2015 update of expert consensus on the diagnosis and treatment of cholestatic liver disease | 2015 | 临床肝胆病杂志2015，31，10： | 65 |
| 8 | 甘草酸制剂肝病临床应用专家共识显示文摘甘草酸制剂是当前肝病领域中用于抗炎保肝治疗的一线药物之一。追溯其历史,甘草酸制剂在20世纪40年代即应用于肝病的治疗,70年代开始有明确的科学性研究论述[1]。目前市场上已经出现甘草酸单铵、复方甘草酸苷、甘草酸二铵、甘草酸二铵脂质体及异甘草酸镁等多种形式的产品。随着研究的不断深入,学术界对甘草酸制剂在各类肝病中的临床应用已积累了较多的循证医学证据,国内外多部肝病相关指南也对甘草酸二铵脂质体及异甘草酸镁等多种形式的产品。 | Expert Committee on Clinical Application of Glycyrrhizin Preparation in the Treatment of Liver Diseases | 2016 | 临床肝胆病杂志2016，32，5： | 51 |
| 9 | 一九九七年全国疟疾形势显示文摘1997年全国疟疾形势基本稳定,疫情报告疟疾发病人数比1996年略有减少,除5个省、市疫情回升外,其余各省、市、自治区疟疾发病率有不同程度降低,没有发生较大范围的暴发流行。防治工作据疟区19个省、直辖市、自治区统计,休止期服药人数为1762892人,... | Advisory Committee on Malaria, MOH | 1998 | 中国寄生虫学与寄生虫病杂志1998，16，3： | 35 |
| 10 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders:executive summary and 2019 update of clinical management of stroke rehabilitation显示文摘Stroke is the third leading cause of long-term disability.Effective stroke rehabilitation should be provided to patients with a moderate or severe stroke so as to achieve functional recovery.Also,stroke rehabilitation is moving towards more intense therapy models that incorporate technologies such as robotics and computer games.Evidence-based guidelines are useful for promoting the best possible clinical practices.This guideline summarises the modes of stroke rehabilitation in China-three-stage rehabilitation network,rehabilitation of stroke dysfunction,training for activities of daily living,stroke complications and rehabilitation care.The aim of this guideline was to provide a synopsis of best clinical practices in the stroke rehabilitation of adult patients in China. | Tong Zhang Jun Zhao Xueping Li Yulong Bai Baojun Wang Yun Qu Bingjie Li Shengjie Zhao Chinese Stroke Association Stroke Council Guideline Writing Committee | 2020 | Stroke & Vascular Neurology2020，5，3： | 38 |
| 11 | 2005年全国治超工作要点显示文摘 | Issued by Ministry of Communications of the People′s Republic of China,T he Ministry of Public Security of the People′s Republic of China,National Development and Reform Comm ission,the Ministry of Propaganda of the CPC Central Committee,General Administration of Qu ality Supervision Inspection and Quarantine of the PRC,State Administration of Work Safety,State Administration for Industry & Commerce,China Legislative | 2005 | 交通标准化2005，，5： | 34 |
| 12 | 乳腺癌分期辨证规范(试行)显示文摘 | Working Committee of Mastopathy,All-China Society of Traditional Chinese Medicine | 2010 | 上海中医药杂志2010，44，1： | 33 |
| 13 | 我国城市生活垃圾处理行业2012年发展综述显示文摘综述了2011年我国生活垃圾处理的发展概况,以及2012年国家发布和实施的有关标准和政策;重点介绍并分析了2012年国内新投入运行的生活垃圾焚烧发电厂和垃圾综合处理厂;对城市生活垃圾处理行业的发展进行了展望。 | (Disposal Committee of Urban Domestic Refuse,CAEPI,Beijing 100037,China) | 2013 | 中国环保产业2013，，3： | 31 |
| 14 | 慢性乙型肝炎特殊患者抗病毒治疗专家共识:2015年更新显示文摘抗病毒治疗是慢性乙型肝炎(CHB)治疗的关键。近年来随着抗病毒治疗不断进展,一般患者的治疗逐渐趋于规范,而CHB特殊患者由于循证医学证据相对不足、相关指南无统一的推荐意见等原因成为临床治疗的难点。为进一步规范这些特殊患者的治疗,2010年《中华实验和临床感染病杂志(电子版)》、《临床肝胆病杂志》与《中国肝脏病杂志(电子版)》编辑部组织相关专家对相关资料进行整理与分析, | Expert Committee for Antiviral Therapy for Special Patients with Chronic Hepatitis B | 2015 | 临床肝胆病杂志2015，31，8： | 32 |
| 15 | 肝纤维化中西医结合诊疗指南显示文摘 | Zhong Xi Yi Jie He Xue Bao Chinese Association of Integrative Medicine, Liver Disease Committee | 2006 | 中西医结合学报2006，4，6： | 29 |
| 16 | 胰腺癌综合诊治中国专家共识(2014年版)显示文摘1前言
据世界卫生组织统计,2008年全球胰腺癌发病率和病死率分别列恶性肿瘤第13位和第7位。2013年最新统计数据显示,在发达国家(美国)胰腺癌新发估计病例数列男性第10位,女性第9位,占恶性肿瘤病死率的第4位。 | The Chinese Society of Clinical Oncology Pancreatic Cancer Expert Committee | 2014 | 临床肝胆病杂志2014，30，10： | 28 |
| 17 | 中国地震烈度区划图(1990)及其说明显示文摘中国地震烈度区划图(1990)采用地震危险性概率分析方法编制,编制中充分考虑了我国地震活动的时、空非均匀性特征,对地震危险性分析方法做了重要改进。在地震活动特点和构造活动特点对比分析的基础上,先划分出26个地震带作为地震活动分析的统计单元,再进一步在地震带内划分潜在震源区,据此将全国划分为733个不同震级上限的潜在震源区。按各震级段地震资料的可信时期,求得地震带的地震重复率系数(b值),并根据对地震活动的时间不均匀性及空间不均匀性分析求得未来时间段的年发生率及其空间分布函数。采用分区烈度椭圆衰减模型,求得全国共约三万个点不同超越概率的烈度值,最后以50年超越概率为10%的风险水平给出1∶400万的中国地震烈度区划图。本图可作为中小工程的抗震设计依据、国土利用规划的基础资料以及制定减轻地震灾害对策的依据。 本图反映了我国八十年代的地震科学水平,也使我国工程建设的抗震设防进入概率设计阶段。 | The Compiling Committee of Seismic Zoning Map in China | 1992 | 中国地震1992，8，4： | 28 |
| 18 | 常见先天性心脏病介入治疗中国专家共识 五、先天性心脏病复合畸形的介入治疗显示文摘先天性心脏复合畸形为同时患有2种或2种以上心血管畸形,能够同期进行介入治疗,其技术操作并非单一技术的简单相加,而有其特殊性。本文介绍室间隔缺损合并房间隔缺损、动脉导管未闭、肺动脉瓣狭窄;房间隔缺损合并动脉导管未闭、肺动脉瓣狭窄、左房室瓣狭窄(鲁登巴赫综合征)及主动脉缩窄合并动脉导管未闭等复合畸形的病理生理改变与临床特点、介入治疗适应证和禁忌证、治疗原则和注意事项、术后处理以及疗效判定等。 | Committee on Congenital Heart Diseases,Internal Medicine Branch of Cadiovascular Diseases,Chinese Physicians’ Association | 2011 | 介入放射学杂志2011，20，5： | 26 |
| 19 | 我国脱硫脱硝行业2013年发展综述显示文摘综述了2013年我国脱硫脱硝行业的发展环境及发展概况;重点介绍了火电行业、钢铁行业、水泥行业脱硫脱硝产业发展现状;分析了行业市场特点及重要动态;针对行业发展中存在的主要问题提出了解决对策和建议。 | Desulfurization and Denitration Committee of CAEPI | 2014 | 中国环保产业2014，，9： | 26 |
| 20 | 国际大学创新力客观评价报告显示文摘“国际大学创新力评价研究”通过设计具有特色的大学创新力客观评价指标体系,对世界高层次大学的创新能力进行评价。该研究的基本方法为指标体系法,指标体系的设计根据社会的需要,坚持科学性、客观性、可比性、创新性、可获取性、合理性的原则,并围绕创新实力、创新活力和创新影响力等一级指标展开。 | Inernational Committee of University Assessment | 2006 | 高等教育研究2006，27，6： | 23 |
您所在的机构暂未开通此部分的功能，请联系管理员